Real-World Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Treated With Pomalidomide Regimens
2d agoen
From the article
Conditions : Relapsed/Refractory Multiple Myeloma Interventions : Drug: Pomalidomide-containing regimens; Drug: Non-pomalidomide-containing regimens Sponsors : Bristol-Myers Squibb Completed
Continue reading on clinicaltrials.govYou might also wanna read
A Guide to Multiple Myeloma Medication Administration Methods and Their Impact on Daily Life
This patient education article explains the different ways multiple myeloma medications are administered — including oral pills, subcutaneou
mdsc.pe·12d agoReal-world data point to patient experience as next battleground for anti-CD20 therapies in RMS, says GlobalData
globaldata.com·5d ago
European Multiple Myeloma Patients Face Unequal Access to Curative Treatments
At the European Hematology Association (EHA) 2026 Congress in Stockholm, speakers highlighted that while new drugs and treatment combination
mdsc.pe·8d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.